52 Days
Source:
The Boston Globe
Analysis of Helena Foulkes on opioids
The article examines Helena Buonanno Foulkes’ tenure as president of CVS Pharmacy and her role in opioid-related initiatives and controversies. It highlights her claims of reducing opioid prescriptions by nearly 40 percent, efforts to identify and block dangerous prescribers, and the company’s drug takeback programs. However, it also discusses ongoing lawsuits against CVS for its role in the opioid crisis, including allegations that the company continued to fill problematic prescriptions during her leadership. Critics point out that broader industry trends contributed to declining opioid prescriptions, complicating claims of CVS’s sole impact.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)